Literature DB >> 19075420

Ocular adnexal lymphoma and infectious agents.

Adriano M Pellicelli, Valerio Zoli, Daniele Remotti.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19075420      PMCID: PMC2661523          DOI: 10.4103/0301-4738.44500

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


× No keyword cloud information.
Dear Editor, We read with interest the article by Das et al.[1] on ocular adnexal lymphoma in the northeast Indian population, but we wish to raise some questions about this article. Marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type is the most frequent non-Hodgkin lymphoma arising from ocular adnexa. Ocular adnexal lymphoma of MALT (OAML) type could be induced by a chronic antigenic stimulation provided by different agents as suggested in different studies.[23] In some cases, a role of Chlamydia psittaci was hypothesized in the etiology of OAML. Tumor regression was observed in patients positive for Chlamydia infection and treated with doxycicline.[4] This supports the hypothesis of some infectious disease agents in the etiology of OAML. As for other B-cell lymphomas, hepatitis C virus (HCV) could play a role in the development of OAML. HCV seropositivity has been detected in 13% of OAML patients and seems to be associated with more aggressive and disseminated lymphomas.[3] In our experience, in a patient affected by OAML and with a chronic active hepatitis C infection, a treatment with pegylated interferon associated to ribavirine has induced a complete remission of the ocular mass and a disappearance of lymphoid infiltrates on bone marrow biopsy. Das et al.[1] did not report whether the patients were positive for an HCV infection or had a positivity for chlamydial infection. As reported above, a bacteria-eradicating therapy as doxycycline or a specific anti-HCV treatment could have been useful as treatment of OAML patients.
  4 in total

1.  Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial.

Authors:  Andrés J M Ferreri; Maurilio Ponzoni; Massimo Guidoboni; Antonio Giordano Resti; Letterio S Politi; Sergio Cortelazzo; Judit Demeter; Francesco Zallio; Angelo Palmas; Giuliana Muti; Giuseppina P Dognini; Elisa Pasini; Antonia Anna Lettini; Federico Sacchetti; Carlo De Conciliis; Claudio Doglioni; Riccardo Dolcetti
Journal:  J Natl Cancer Inst       Date:  2006-10-04       Impact factor: 13.506

2.  Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas.

Authors:  Andrés J M Ferreri; Massimo Guidoboni; Maurilio Ponzoni; Carlo De Conciliis; Stefania Dell'Oro; Katharina Fleischhauer; Laura Caggiari; Antonia A Lettini; Elena Dal Cin; Rossella Ieri; Massimo Freschi; Eugenio Villa; Mauro Boiocchi; Riccardo Dolcetti
Journal:  J Natl Cancer Inst       Date:  2004-04-21       Impact factor: 13.506

3.  Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa.

Authors:  A J M Ferreri; E Viale; M Guidoboni; A Giordano Resti; C De Conciliis; L Politi; A A Lettini; F Sacchetti; R Dolcetti; C Doglioni; M Ponzoni
Journal:  Ann Oncol       Date:  2006-03-08       Impact factor: 32.976

4.  Ocular adnexal lymphoma in the Northeast Indian population.

Authors:  Dipankar Das; Panna Deka; Kasturi Bhattacharjee; Jayanta Kumar Das; Ganesh Kuri; Akshay Chandra Deka; Harsha Bhattacharjee
Journal:  Indian J Ophthalmol       Date:  2008 Mar-Apr       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.